Pharmaceutical controlled release tablets containing a carrier made of cross-linked amylose and hydroxypropylmethylcellulose

MYPI1997001576A0Inactive Publication Date: 1997-10-10LABOPHARM INC +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI1997001576
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
1996-04-10
Filing Date
1997-04-10
Publication Date
1997-10-10
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

DISCLOSED IS A PHARMACEUTICAL CONTROLLED RELEASE TABLET CONTAINING AN ACTIVE INGREDIENT IN COMBINATION WITH A CARRIER MADE OF CROSS-LINKED AMYLOSE IN WHICH HYDROXYMETHYLPROPYLCELLULOSE (HPMC) WITH A VISCOSITY HIGHER THAN OR EQUAL TO 4000 CPS IS ADDED AS AN ADJUVANT. THE ADDITION OF HPMC TO THE TABLET PERMITS TO CONTROL THE EFFECT OF ENZYMES, AND MORE PARTICULAR ALPHA-AMYLASE PRESENT IN THE INTESTINAL MEDIUM, ON THE CROSS-LINKED AMYLOSE USED AS A CARRIER, AND THUS TO REDUCE THE DEPENDENCE OF THE KINETICS OF RELEASE UPON THE CONCENTRATION OF ENZYMES PRESENT IN THE MEDIUM.
Need to check novelty before this filing date? Find Prior Art